secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001493152-26-012173
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio grants restricted shares to CEO/CFO/directors; updates ATM facility
--------------------------------------------------------------------------------

- CEO Harry Simeonidis and CFO Spiro Sakiris each receive 9,150 time-vesting and 21,350 performance-vesting restricted shares.
- Directors awarded 20,000 time-vesting shares; non-executive employees get 10,500 time-vesting and 24,500 performance-vesting shares.
- Total outstanding shares as of March 23, 2026: 2,001,173, reflecting grants and warrant exercises.
- Up to $3,966,316 in shares available for sale under existing ATM agreement with Ladenburg Thalmann; new prospectus supplement filed.
- Performance-vesting shares tied to clinical trial, FDA submission, and commercial milestones; vest over up to 10 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/0001493152-26-012173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer